Advertisements


Sanofi dengue vaccine increased risk of hospitalization, Reuters says

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2018

AstraZeneca revises down its vaccine efficacy in a huge US trial, from 79% to 76%, following concerns from Fauci and other experts that the results were outdated

AstraZeneca said Thursday in updated results that its COVID-19 vaccine was still 100% effective at preventing severe disease and hospitalization. Dr. Anthony Fauci. Reuters, Al Drago/AFP via Getty Images AstraZeneca said Thursday i.....»»

Category: smallbizSource: nytMar 25th, 2021

AstraZeneca COVID-19 vaccine: No link to increased risk of blood clots, benefits outweigh risks, EU agency says

Concerns over the clotting led more than a dozen European countries to suspend use of the vaccine over the past week.Concerns over the clotting led more than a dozen European countries to suspend use of the vaccine over the past week......»»

Category: topSource: chicagotribuneMar 18th, 2021

AstraZeneca Review Finds COVID-19 Vaccine Doesn"t Increase Risk Of Blood Clots

AstraZeneca Plc (NASDAQ: AZN) said on Sunday that a review of safety data of more than 17 million people vaccinated with its COVID-19 vaccine in the European Union and the United Kingdom showed no evidence of an increased risk of blood clots. read more.....»»

Category: blogSource: benzingaMar 15th, 2021

: Single dose of AstraZeneca or Pfizer COVID-19 vaccine cuts hospitalization risk by more than 80%, study shows

France revises its stance and approves the AstraZeneca–Oxford vaccine for the over-65s......»»

Category: topSource: marketwatchMar 3rd, 2021

Anti-vaxxers are using a doctor"s miscarriage to claim the COVID-19 vaccine affects pregnancy - but the doctor lost her baby before getting the shot

There's no evidence the coronavirus vaccine is linked to an increased risk of pregnancy complications. Due to how it's made, it's expected to be safe. Getty A Facebook post allegedly claimed the coronavirus vaccine caused.....»»

Category: topSource: businessinsiderFeb 9th, 2021

: CDC issues COVID-19 vaccine guidance for Americans with HIV, Guillain-Barré and other underlying conditions

‘Adults of any age with certain underlying medical conditions are at increased risk for severe illness from the virus that causes COVID-19.’.....»»

Category: topSource: marketwatchJan 1st, 2021

Sanofi walked back a promise to give the US priority access to its coronavirus vaccine after outrage from the French government

Sean Elias/Handout via REUTERS French pharmaceutical giant scrapped a plan to give the US pri.....»»

Category: topSource: businessinsiderMay 15th, 2020

Sanofi to speed up European COVID-19 vaccine access, Reuters says

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 13th, 2020

Some militaries and militants see an opportunity in the coronavirus crisis

REUTERS/Danish Ismail The overwhelming amount of public attention, political bandwidth, and government resources being devoted to the coronavirus outbreak could open up security vacuums around the world. With an increased tolerance for risk.....»»

Category: topSource: businessinsiderMar 19th, 2020

Pfizer, Sanofi to boost South Africa"s Biovac vaccine output, Reuters reports

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 2nd, 2019

Brainstorm Health: Opioid Crisis Reckoning, Sanofi Dengue Vaccine, Human Trafficking

Brainstorm Health Daily: May 2, 2019 Good afternoon, rea.....»»

Category: europeSource: fortuneMay 2nd, 2019

The Daily Biotech Pulse: FDA Nod For Sanofi"s Dengue Vaccine, Veracyte Offering, Biogen Reports Positive Data

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 1) read more.....»»

Category: blogSource: benzingaMay 2nd, 2019

Violence is high in Mexico"s most popular tourist destinations — but some groups are more at risk

REUTERS/Javier Verdin Deadly violence has increased in Mexico over the past several years. Tourist areas in particular have .....»»

Category: topSource: businessinsiderApr 18th, 2018

Sanofi dengue vaccine gets recommendation for European approval

Sanofi S.A.'s dengue vaccine, Dengvaxia, has been recommended for approval in Europe by the European Medicines Agency's Committee for Medicinal Products for Human Use, the compa.....»»

Category: topSource: marketwatchOct 19th, 2018

Sanofi receives positive CHMP opinion for dengue vaccine

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 19th, 2018

Sanofi dengue vaccine Dengvaxia approved in Europe

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 19th, 2018

Undeterred by Sanofi"s stumble, Takeda takes similar path with dengue shot

A new vaccine for the dengue virus is taking a potentially risky road to prevent the mosquito-borne disease that infects nearly 400 million people each year......»»

Category: topSource: reutersJan 30th, 2019

Bitcoin"s sell-off could continue another 18% lower as the crypto breaks through a key support level, technical analyst says

"We see the pullback as an interruption in the uptrend, not the start of a bearish reversal, given the recent breakout above the 2021 high." Lauren DeCicca/Getty Images; Jenny Chang-Rodriguez/BIBitcoin faces an increased risk of falling 18% afte.....»»

Category: topSource: businessinsiderApr 16th, 2024

Pfizer Stock Rises on Upbeat RSV Vaccine Trial Data

Pfizer Inc (NYSE: PFE) stock is up 1.7% at $27.04 at last check, following news a late-stage trial of its respiratory syncytial virus (RSV) vaccine Abrysvo generated an immune response in higher risk adults under the age of 60. read more.....»»

Category: blogSource: benzingaApr 11th, 2024

An Ohio state representative is trying to block the state"s $5 million vaccine lottery

Ohio Rep. Jena Powell told CNN's "New Day" on Monday that the COVID-19 vaccine lottery is a "gross misuse of taxpayer dollars." Dado Ruvic/Reuters An Ohio state lawmaker says she'll try to block the state's vaccine lottery.....»»

Category: dealsSource: nytMay 24th, 2021